Baxter International Inc. vs Pfizer, Inc. — Stock Comparison
Q·Score Breakdown
4.8
Bearish
Overall
6.5
Neutral
Quality
Health
Growth
Valuation
Sentiment
BAX
Consensus analyst target of $22.12 is 29% above current price.
⚠ currently unprofitable (-10% margin).
PFE
Strong profitability with 12% net profit margins.
⚠ analyst sentiment is cautious.
Analyst Consensus
HOLD
Target $22.12 (+28.5%)
13 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts
Fundamentals
BAX
PFE
—
Trailing P/E
19.4×
8.5×
Forward P/E
9.4×
-9.7%
Profit Margin
12.4%
34.6%
Gross Margin
75.8%
—
ROE
8.9%
2.9%
Revenue Growth
-1.2%
—
Earnings Growth
—
0.62
Beta
0.39
—
Price / Book
—
$8.9B
Market Cap
$149.8B
$16 – $33
52-Week Range
$22 – $29
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →